BR0215098A - Composição útil para remoção de coágulos de sangue, método para a remoção de coágulos de sangue, catéter e embalagens de múltiplos compartimentos - Google Patents

Composição útil para remoção de coágulos de sangue, método para a remoção de coágulos de sangue, catéter e embalagens de múltiplos compartimentos

Info

Publication number
BR0215098A
BR0215098A BR0215098-0A BR0215098A BR0215098A BR 0215098 A BR0215098 A BR 0215098A BR 0215098 A BR0215098 A BR 0215098A BR 0215098 A BR0215098 A BR 0215098A
Authority
BR
Brazil
Prior art keywords
blood clots
removing blood
catheter
composition
useful composition
Prior art date
Application number
BR0215098-0A
Other languages
English (en)
Inventor
Charles P Semba
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BR0215098A publication Critical patent/BR0215098A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

"COMPOSIçãO úTIL PARA A REMOçãO DE COáGULOS DE SANGUE, MéTODO PARA A REMOçãO DE COáGULOS DE SANGUE, CATéTER E EMBALAGENS DE MúLTIPLOS COMPARTIMENTOS". Composição útil para a remoção de coágulos sang³íneos ligados por fibrina de um catéter compreende água, quantidade fibrinoliticamente eficaz de ativador de plasminogênio e quantidade eficaz como conservante de álcool orgânico bacteriostático. A composição não compreende agente quelante.
BR0215098-0A 2001-11-26 2002-11-25 Composição útil para remoção de coágulos de sangue, método para a remoção de coágulos de sangue, catéter e embalagens de múltiplos compartimentos BR0215098A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26
PCT/US2002/037878 WO2003045466A2 (en) 2001-11-26 2002-11-25 Catheter composition and uses thereof

Publications (1)

Publication Number Publication Date
BR0215098A true BR0215098A (pt) 2004-12-14

Family

ID=23302492

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215098-0A BR0215098A (pt) 2001-11-26 2002-11-25 Composição útil para remoção de coágulos de sangue, método para a remoção de coágulos de sangue, catéter e embalagens de múltiplos compartimentos

Country Status (28)

Country Link
US (3) US20030206906A1 (pt)
EP (1) EP1455858A4 (pt)
JP (1) JP4458240B2 (pt)
KR (2) KR20040054803A (pt)
CN (1) CN100478027C (pt)
AR (1) AR037437A1 (pt)
AU (2) AU2002365408B2 (pt)
BR (1) BR0215098A (pt)
CA (1) CA2467645C (pt)
CO (1) CO5580795A2 (pt)
EA (1) EA007594B1 (pt)
EC (2) ECSDI045123S (pt)
HR (1) HRP20040502A2 (pt)
HU (1) HUP0600436A3 (pt)
IL (2) IL162083A0 (pt)
IS (1) IS7275A (pt)
ME (1) ME00015B (pt)
MX (1) MXPA04004948A (pt)
MY (1) MY140404A (pt)
NO (1) NO331700B1 (pt)
NZ (1) NZ533029A (pt)
PL (1) PL371760A1 (pt)
RS (1) RS46204A (pt)
TW (1) TWI262794B (pt)
UA (1) UA81235C2 (pt)
UY (1) UY27550A1 (pt)
WO (1) WO2003045466A2 (pt)
ZA (1) ZA200404024B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162083A0 (en) 2001-11-26 2005-11-20 Genentech Inc Catheter composition and uses thereof
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
CN101563100B (zh) * 2006-08-28 2013-08-07 李季男 用于预防和治疗牙周病、改善牙周创伤愈合以及促进口腔健康的新药物靶标
CA2662083C (en) * 2006-08-28 2016-09-20 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
JP5871449B2 (ja) * 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用
EP2160152B1 (en) 2007-06-01 2016-07-27 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
CA2698721A1 (en) * 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
WO2011019710A2 (en) * 2009-08-10 2011-02-17 Proviflo, Llc Catheter lock solutions utilizing tocopheraol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
WO1991017724A1 (en) * 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
PT786257E (pt) * 1992-06-03 2003-12-31 Genentech Inc Variantes de glicosilacao do activador de plasminogenio tissular com propriedades terapeuticas meloradas
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5362754A (en) 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
BR9408137A (pt) 1993-11-24 1997-08-12 Du Pont Merck Pharma Composto éster de prodroga método de tratamento composição farmacêutica e método de inibição
US5849736A (en) 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
WO1998028326A1 (en) 1996-12-23 1998-07-02 Biochem Pharma Inc. Bicyclic thrombin inhibitors
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
EP1189663A2 (en) 1999-03-11 2002-03-27 Du Pont Pharmaceuticals Company Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders
IL144798A0 (en) 1999-03-11 2002-06-30 Du Pont Pharm Co Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
ATE394134T1 (de) 2000-05-10 2008-05-15 Ash Access Technology Inc Kathetersperrlösung mit photo-oxidant
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
IL162083A0 (en) 2001-11-26 2005-11-20 Genentech Inc Catheter composition and uses thereof
US20070014779A1 (en) 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
DE60311958T2 (de) 2003-02-03 2007-11-08 Polaschegg, Hans-Dietrich, Dr. Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
JP5871449B2 (ja) 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用

Also Published As

Publication number Publication date
US20060246050A1 (en) 2006-11-02
PL371760A1 (en) 2005-06-27
HUP0600436A3 (en) 2010-12-28
US20060257390A1 (en) 2006-11-16
EA200400712A1 (ru) 2005-06-30
NO20042693L (no) 2004-08-25
ZA200404024B (en) 2005-07-27
JP4458240B2 (ja) 2010-04-28
TWI262794B (en) 2006-10-01
US20030206906A1 (en) 2003-11-06
EP1455858A2 (en) 2004-09-15
NO331700B1 (no) 2012-02-27
HRP20040502A2 (en) 2004-12-31
ME00015B (me) 2010-06-10
MEP8008A (xx) 2010-02-10
CN1617738A (zh) 2005-05-18
IS7275A (is) 2004-05-21
AR037437A1 (es) 2004-11-10
CA2467645A1 (en) 2003-06-05
NZ533029A (en) 2006-05-26
EP1455858A4 (en) 2006-02-15
CN100478027C (zh) 2009-04-15
KR20100102745A (ko) 2010-09-24
HUP0600436A2 (en) 2006-09-28
AU2002365408B2 (en) 2008-04-24
KR20040054803A (ko) 2004-06-25
CO5580795A2 (es) 2005-11-30
RS46204A (en) 2006-10-27
MXPA04004948A (es) 2004-08-11
WO2003045466A3 (en) 2003-10-09
UA81235C2 (en) 2007-12-25
CA2467645C (en) 2017-01-17
UY27550A1 (es) 2003-06-30
IL162083A (en) 2012-12-31
AU2008203131A1 (en) 2008-08-07
TW200303743A (en) 2003-09-16
ECSDI045123S (pt) 2004-07-23
WO2003045466A2 (en) 2003-06-05
JP2005510302A (ja) 2005-04-21
EA007594B1 (ru) 2006-12-29
ECSP045123A (es) 2004-07-23
US7829082B2 (en) 2010-11-09
MY140404A (en) 2009-12-31
AU2002365408A1 (en) 2003-06-10
IL162083A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
BR0215098A (pt) Composição útil para remoção de coágulos de sangue, método para a remoção de coágulos de sangue, catéter e embalagens de múltiplos compartimentos
ES2166638T3 (es) Procedimiento y dispositivo para la esterilizacion de cuerpos huecos.
CO5300404A1 (es) Sistema y metodo para esterilizar un area de empaque de alimentos
AR028706A1 (es) Tiazina oxazolidinona
BR9207002A (pt) Preparação de osso para transplantação
CA2260832A1 (en) Use of a combination of surfactants, chelating agents and essential oils for effective disinfection
PT1047406E (pt) Composicoes farmaceuticas autoclavaveis contendo um agente quelante
DE69718352D1 (de) Antiseptisches reinigungsmittel für die hygienische und chirurgische desinfektion der hände
DE69026112D1 (de) Nichtoxidierend wirkende ophthalmische zusammensetzungen und verfahren zu ihrer konservierung und anwendung
AR019735A1 (es) Articulo absorbente adaptado para recibir heces
WO1999032158A3 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
BR0200001A (pt) Sistema, método e aparelho para esterilizar garrafas
ATE261394T1 (de) Verfahren zur abschnittsweisen cip-reinigung
MX169931B (es) Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas
DE69939482D1 (de) Entfettungsmittel und verfahren, die diese zusammensetzung benutzen
ATE372132T1 (de) Verfahren zum sterilisieren von gegenständen
ATE291933T1 (de) Hochdruck-sterilisation von empfindlichen wirkstoffen
AR025189A1 (es) Tampon y proceso para su fabricacion
DE60113083D1 (de) Verfahren zum Desinfizieren und/oder Sterilisieren einer zahnärztlichen Einheit.
FR2770135B1 (fr) Agent bacteriostatique, sa preparation et son utilisation
ATE267616T1 (de) Sterilisationsmittel und -verfahren
GT199900076A (es) Composicion y metodo.
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
ITMI20001477A0 (it) Procedimento a dispositivo per trattare minuteria con un agente di trattamento liquido.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2281 DE 23/09/2014.